Tumor-associated high endothelial venules mediate lymphocyte entry into tumors and predict response to PD-1 plus CTLA-4 combination immunotherapy-Reference-Cited by-同舟云学术

Tumor-associated high endothelial venules mediate lymphocyte entry into tumors and predict response to PD-1 plus CTLA-4 combination immunotherapy

Published:2022-03 Issue:3 Volume:40 Page:318-334.e9
ISSN:1535-6108
Container-title:Cancer Cell
language:en
Short-container-title:Cancer Cell

Author:

Asrir Assia,Tardiveau Claire,Coudert Juliette,Laffont Robin^ORCID,Blanchard Lucas,Bellard Elisabeth,Veerman Krystle,Bettini Sarah,Lafouresse Fanny,Vina Estefania,Tarroux Dorian,Roy Severine,Girault Isabelle,Molinaro Irma^ORCID,Martins Frédéric^ORCID,Scoazec Jean-Yves,Ortega Nathalie,Robert Caroline,Girard Jean-Philippe^ORCID

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference60 articles.

1. Combined antiangiogenic and anti-PD-L1 therapy stimulates tumor immunity through HEV formation;Allen;Sci. Transl Med.,2017

2. Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma;Amaria;Nat. Med.,2018

3. High endothelial venules (HEVs) in immunity, inflammation and cancer;Blanchard;Angiogenesis,2021

4. Trimmomatic: a flexible trimmer for Illumina sequence data;Bolger;Bioinformatics,2014

5. PD-L1 blockade therapy: location, location, location;Brown;Cancer Cell,2020

Cited by 125 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tertiary lymphoid structures as potential biomarkers for cancer prediction and prognosis;International Immunopharmacology;2024-10

2. Progress in Immune Checkpoint Inhibitor for Melanoma Therapy;Hematology/Oncology Clinics of North America;2024-10

3. Phenotypic and spatial heterogeneity of CD8+ tumour infiltrating lymphocytes;Molecular Cancer;2024-09-09

4. Abscopal effect: from a rare phenomenon to a new frontier in cancer therapy;Biomarker Research;2024-09-04

5. A systems view of the vascular endothelium in health and disease;Cell;2024-09